{
    "clinical_study": {
        "@rank": "67190", 
        "arm_group": {
            "arm_group_label": "Pharmacokinetics Moxifloxacin", 
            "description": "Patients with pneumonia treated with Moxifloxacin"
        }, 
        "biospec_descr": {
            "textblock": "Whole blood"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "At the Department of Infectious Diseases, Aarhus Denmark, Moxifloxacin is used in the\n      treatment of severe pneumonia. Due to the risk of cardiac toxicity, it is not recommended to\n      give more than one dose of 400 mg daily. To investigate if this dose is enough to eradicate\n      the bacteria, the investigators take a blood test from the patients treated with\n      Moxifloxacin to determine the concentration og Moxifloxacin in the blood.\n\n      Our hypothesis is, that 400 mg of Moxifloxacin is not enough in the treatment of severe\n      pneumonia."
        }, 
        "brief_title": "Pharmacokinetics of Moxifloxacin in Patients With Pneumonia", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Pneumonia", 
        "condition_browse": {
            "mesh_term": "Pneumonia"
        }, 
        "detailed_description": {
            "textblock": "At the Department of Infectious Diseases, Aarhus Denmark, Moxifloxacin is used in the\n      treatment of severe pneumonia. Due to the risk of cardiac toxicity, it is not recommended to\n      give more than one dose of 400 mg daily. To investigate if this dose is enough to eradicate\n      the bacteria, we take a total of 4 blood tests from the patients treated with Moxifloxacin,\n      to determine the concentration og Moxifloxacin in the blood and calculate the\n      pharmacokinetics.\n\n      We compare the  blood concentration with the minimal inhibitory concentration (MIC)for the\n      bacteria found in the sputum or blood, or with known MIC-values for the most common\n      bacterias causing pneumonia in Denmark."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with pneumonia,\n\n          -  Treated with Moxifloxacin\n\n        Exclusion Criteria:\n\n          -  Under 18 years of age"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with pneumonia, admitted to the Department of Infectious diseases, Aarhus\n        University Hospital, Denmark"
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01983839", 
            "org_study_id": "MOXI-274-13", 
            "secondary_id": "2007-58-0010"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Moxifloxacin", 
                "Norgestimate, ethinyl estradiol drug combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Moxifloxacin", 
            "Pneumonia", 
            "Pharmacokinetics"
        ], 
        "lastchanged_date": "November 13, 2013", 
        "location": {
            "contact": {
                "email": "krisoebr@rm.dk", 
                "last_name": "Kristina \u00d6brink-Hansen, MD", 
                "phone": "+45 7845 2845"
            }, 
            "contact_backup": {
                "email": "joepeter@rm.dk", 
                "last_name": "Eskild Petersen, MD, Assoc. Prof., D.Sc.", 
                "phone": "+45 7845 2817"
            }, 
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "state": "Aarhus N", 
                    "zip": "8200"
                }, 
                "name": "Department of Infectious Diseases, Aarhus University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_groups": "1", 
        "official_title": "Pharmacokinetics of Moxifloxacin in Patients With Pneumonia", 
        "overall_contact": {
            "email": "krisoebr@rm.dk", 
            "last_name": "Kristina \u00d6brink-Hansen, MD", 
            "phone": "+45 7845 2845"
        }, 
        "overall_contact_backup": {
            "email": "joepeter@rm.dk", 
            "last_name": "Eskild Petersen, MD, Assoc. Prof., D.Sc.", 
            "phone": "7845 2817"
        }, 
        "overall_official": {
            "affiliation": "Department of Infectious Diseases, Aarhus University Hospital, Denmark", 
            "last_name": "Eskild Petersen, MD, Assoc. Prof., D.Sc.", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The concentration of Moxifloxacin in blood-plasma", 
            "safety_issue": "No", 
            "time_frame": "The first 3 days of Moxifloxacin treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01983839"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Aarhus", 
            "investigator_full_name": "Kristina \u00d6brink-Hansen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Aarhus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}